APG-808

N/A

Report date: 2024/03/28 11:55:28

Base Information

Drug NameAPG-808
Drug Alias NameAPG-808APG808PR-001PR001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-4 receptor subunit alpha blockers
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesParagon Therapeutics IncApogee Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesParagon Therapeutics IncApogee Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A